STIFEL FINANCIAL CORP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$482,542
+12.9%
23,550
+9.5%
0.00%0.0%
Q2 2023$427,530
+30.8%
21,516
+12.8%
0.00%
Q1 2023$326,836
+1.0%
19,080
+15.4%
0.00%
Q4 2022$323,533
+45.1%
16,532
+18.4%
0.00%
Q3 2022$223,00013,9610.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders